Literature DB >> 8082076

The argyrophilic nucleolar organizer regions in ductal carcinoma in situ of the breast. The significance of ploidy and proliferative activity analysis using this silver staining technique.

W A Mourad1, S Setrakian, M L Hales, M Abdulla, G Trucco.   

Abstract

BACKGROUND: Two interphase argyrophilic nucleolar organizer region (AgNOR) counts have been correlated with ploidy and proliferative activity in patients with ductal carcinoma in situ (DCIS) of the breast. The first is the mean number of AgNORs (mAgNOR); it reflects ploidy. The second is the percentage of nuclei with greater than or equal to five AgNORs/nucleus (pAgNOR); it correlates with proliferative activity. DCIS of the breast is a heterogeneous group of lesions that is not associated uniformly with invasive ductal carcinoma. A significant number of patients with DCIS will, however, progress to invasive ductal carcinoma. Factors identifying the invasive potential of DCIS in these patients have not been defined clearly. The authors postulated that pAgNOR in DCIS may predict the invasive potential of these lesions.
METHODS: The authors studied 86 cases of DCIS of the breast by the AgNOR silver stain using the two above-mentioned counts.
RESULTS: There were 54 comedo and 32 noncomedo DCIS cases. Forty-one cases (47%) were associated with invasive ductal carcinoma. Thirty cases of comedo DCIS (55%) showed mAgNOR counts suggestive of aneuploidy (> or = 2.4/nucleus), whereas only seven cases of noncomedo DCIS (22%) showed such counts (P = 0.001). Cases associated with invasion had higher incidence of aneuploid mAgNOR counts (P = 0.0003). The pAgNOR counts in comedo DCIS ranged from 1% to 36% (median, 11%), whereas in noncomedo DCIS pAgNOR counts ranged from 0% to 22% (median, 7%) (P = 0.007). The 41 cases associated with invasion had pAgNOR counts ranging from 3% to 36% (median, 12%), whereas those not associated with invasion had pAgNOR counts ranging from 0% to 24% (median, 5%) (P = 0.000001). This difference was irrespective of the type of DCIS or mAgNOR counts.
CONCLUSIONS: Comedo DCIS of the breast may show a higher incidence of aneuploidy and increased proliferative activity and invasive ductal carcinoma than does noncomedo DCIS. Ploidy and proliferative activity, measured by AgNOR staining in DCIS, may have a significant predictive value in identifying the invasive potential of these lesions.

Entities:  

Mesh:

Year:  1994        PMID: 8082076     DOI: 10.1002/1097-0142(19940915)74:6<1739::aid-cncr2820740616>3.0.co;2-t

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Interphase cytogenetic and AgNOR analyses of hydatidiform moles.

Authors:  M Watanabe; M Ghazizadeh; H Konishi; T Araki
Journal:  J Clin Pathol       Date:  1998-06       Impact factor: 3.411

2.  Prognostic significance of MIB1-determined proliferative activities in intraductal components and invasive foci associated with invasive ductal breast carcinoma.

Authors:  H Imamura; S Haga; T Shimizu; O Watanabe; T Kajiwara; M Aiba
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

3.  Comparative analyses between the smoking habit frequency and the nucleolar organizer region associated proteins in exfoliative cytology of smokers' normal buccal mucosa.

Authors:  Renata Pittella Cançado; Liliane Soares Yurgel; Manoel Sant'anna Filho
Journal:  Tob Induc Dis       Date:  2004-03-15       Impact factor: 2.600

4.  Assessment of the argyrophilic nucleolar organizer region area/nucleus ratio in ovarian serous epithelial adenomas, borderline tumors and cancers.

Authors:  Leszek Gottwald; Marian Danilewicz; Jacek Suzin; Malgorzata Wagrowska-Danilewicz; Michal Spych; Wieslaw Tylinski; Katarzyna Topczewska-Tylinska; Janusz Piekarski; Sylwia Kazmierczak-Lukaszewicz; Aleksandra Cialkowska-Rysz
Journal:  Arch Med Sci       Date:  2013-02-18       Impact factor: 3.318

5.  The AgNORs count in predicting long-term survival in serous ovarian cancer.

Authors:  Leszek Gottwald; Marian Danilewicz; Wojciech Fendler; Jacek Suzin; Michal Spych; Janusz Piekarski; Wieslaw Tylinski; Justyna Chalubinska; Katarzyna Topczewska-Tylinska; Aleksandra Cialkowska-Rysz
Journal:  Arch Med Sci       Date:  2013-08-12       Impact factor: 3.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.